Provided by Tiger Trade Technology Pte. Ltd.

Phathom Pharmaceuticals

8.87
+0.27003.14%
Pre-market: 8.83-0.0393-0.44%08:37 EDT
Volume:979.41K
Turnover:8.64M
Market Cap:717.59M
PE:-7.01
High:8.90
Open:8.63
Low:8.59
Close:8.60
52wk High:18.31
52wk Low:8.21
Shares:80.90M
Float Shares:63.93M
Volume Ratio:0.93
T/O Rate:1.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2659
EPS(LYR):-3.0342
ROE:-3489.00%
ROA:-8.80%
PB:-2.08
PE(LYR):-2.92

Loading ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), Pfizer (PFE) and Guardant Health (GH)

TIPRANKS
·
Apr 28

Phathom Pharmaceuticals to report first-quarter results, host webcast and conference call

Reuters
·
Apr 20

Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026

GlobeNewswire
·
Apr 20

A Look At Phathom Pharmaceuticals (PHAT) Valuation After Recent Stock Momentum Shift

Simply Wall St.
·
Apr 15

Phathom Pharmaceuticals announces annual shareholder meeting via webcast

Reuters
·
Apr 07

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Apr 06

BUZZ-U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services

Reuters
·
Mar 27

Phathom Pharmaceuticals Raised to Overweight From Equal-Weight by Barclays

Dow Jones
·
Mar 27

BUZZ- Barclays raises Phathom Pharmaceuticals to 'overweight'; shares rise

Reuters
·
Mar 27

Phathom Pharmaceuticals Inc. : Barclays Raises Target Price to $18 From $16

THOMSON REUTERS
·
Mar 27

Phathom Pharmaceuticals upgraded to Overweight from Equal Weight at Barclays

TIPRANKS
·
Mar 27

U.S. RESEARCH ROUNDUP- Brown-Forman, Chord Energy, Olaplex Holdings

Reuters
·
Mar 27

Phathom Pharmaceuticals management to meet with Cantor

TIPRANKS
·
Mar 24

Phathom Pharmaceuticals Charts Profitable Path After Ramp-Up

TIPRANKS
·
Mar 05

Phathom Pharmaceuticals Is Maintained at Buy by Guggenheim

Dow Jones
·
Feb 27

Phathom Pharmaceuticals price target raised to $25 from $20 at Guggenheim

TIPRANKS
·
Feb 27

Phathom Pharmaceuticals: Early VOQUEZNA Traction, Strengthened Balance Sheet, and Clear Path to Profitability Support Buy Rating

TIPRANKS
·
Feb 27

Analysts’ Top Healthcare Picks: Phathom Pharmaceuticals (PHAT), Certara (CERT)

TIPRANKS
·
Feb 27

Analysts Have Conflicting Sentiments on These Healthcare Companies: Phathom Pharmaceuticals (PHAT), BioLife Solutions (BLFS) and RxSight (RXST)

TIPRANKS
·
Feb 27

Phathom Pharmaceuticals Q4 revenue slightly beats expectations

Reuters
·
Feb 26